It is shown that a sustained level of GM-CSF and IL-2 at the vaccination site is important for the activation of anti-tumor immune response [13], as GM-CSF acts to recruit DCs to present antigen, and IL-2 strengthens the T-cell response. This evidence concerns the gene CSF2 and neoplasm.